Graham G. Walmsley (CIK 1777517) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-09). Recent activity: Sell AKRO (93,000 shares), Sell AKRO (1.2M shares), Sell AKRO (9,398 shares), Buy AKRO (26,000 shares), Buy AKRO (15,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Director | Sell | 93,000 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Director | Sell | 1.2M | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Director | Sell | 9,398 | $0 |
| 2025-10-10 | Akero Therapeutics, Inc. (AKRO) | Director | Buy | 26,000 | $598,520 |
| 2025-10-10 | Akero Therapeutics, Inc. (AKRO) | Director | Buy | 15,000 | $121,950 |
| 2025-10-10 | Akero Therapeutics, Inc. (AKRO) | Director | Buy | 13,000 | $342,160 |
| 2025-10-10 | Akero Therapeutics, Inc. (AKRO) | Director | Buy | 13,000 | $327,600 |
| 2025-10-10 | Akero Therapeutics, Inc. (AKRO) | Director | Buy | 23,832 | $475,925 |
| 2025-06-05 | Akero Therapeutics, Inc. (AKRO) | Director | Buy | 9,398 | $0 |
来源：SEC Form 4 申报文件 · 截至 2025-12-09